Back to Journals » International Journal of General Medicine » Volume 17
Low Prognostic Nutritional Index (PNI) Level is Associated with an Increased Risk of Neonatal Respiratory Distress Syndrome in Preterm Infants with Different Gestational Ages: A Retrospective Study
Authors Huang L, Chen X
, Zhang Y
Received 9 July 2024
Accepted for publication 8 November 2024
Published 12 November 2024 Volume 2024:17 Pages 5219—5231
DOI https://doi.org/10.2147/IJGM.S486224
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Woon-Man Kung
Liudan Huang,1 Xuexin Chen,2 Yuhua Zhang1
1Department of Pediatrics, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Department of Neonatology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China
Correspondence: Liudan Huang, Department of pediatrics, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China, Email [email protected]
Background: Neonatal respiratory distress syndrome (NRDS) is common in preterm infants. Prognostic nutritional index (PNI)((albumin (g/L)+(5×total lymphocyte count (109/L)) is a comprehensive indicator of nutritional and immune levels, and associated with several diseases. The relationship between PNI and the risk of NRDS in newborns of different gestational ages remains unclear.
Methods: A total of 2722 preterm infants were included in this retrospective study. PNI level and clinical records of these neonates (adverse pregnancy and birth history, amniotic fluid contamination, nuchal cord, placental abnormality, mode of delivery, gender and birth weight of neonates, Apgar scores) were collected. The clinical features of the infants with and without NRDS were compared. Logistic regression analysis was used to evaluate the relationship between PNI and NRDS in newborns with different gestational ages.
Results: There were 1226 neonates with NRDS and 1496 without NRDS. The differences in the proportions of placenta abnormality, cesarean section, and small for gestational age (SGA) among infants with 34– 37 weeks, 28+1-33+6 weeks, and ≤ 28 weeks gestational age were statistically significant. Logistic analysis showed that cesarean section (odds ratio (OR): 1.550, 95% confidence interval (CI): 1.197– 2.007, p=0.001), and low PNI (OR: 1.417, 95% CI: 1.110– 1.808, p=0.005) were associated with NRDS in infants born at 34– 37 weeks gestational. Adverse pregnancy and birth history (OR: 1.507, 95% CI: 1.124– 2.019, p=0.006), SGA (OR: 1.994, 95% CI: 1.455– 2.733, p< 0.001), and low PNI (OR: 1.626, 95% CI: 1.230– 2.149, p=0.001) were associated with NRDS in infants with 28+1-33+6 weeks gestational age. Low PNI (OR: 5.512, 95% CI: 1.555– 19.536, p=0.008) was associated with NRDS in infants with ≤ 28 weeks gestational age.
Conclusion: The risk factors for NRDS in preterm infants with different gestational ages were different. But the low PNI level is associated with an increased risk of NRDS in preterm infants with all different gestational ages.
Keywords: neonatal respiratory distress syndrome, preterm infants, risk factors, prognostic nutritional index
Introduction
Preterm birth refers to births that occur at a gestational age <37 weeks according to the American College of Obstetricians and Gynecologists (ACOG).1 Preterm infant is a live birth neonate less than 37 weeks of gestational age.2 Pulmonary surfactant can reduce the surface tension of the alveoli, so that the alveoli open, thereby maintaining the stability of the alveoli, so as to ensure normal breathing.3,4 Due to the immature development of preterm infants, the alveolar epithelial cells that synthesize pulmonary surfactants are lacking.5–7 When the pulmonary surfactant is insufficient, the alveolar surface tension increases, the alveolar collapse is easy, and progressive atelectasis occurs, leading to the occurrence of neonatal respiratory distress syndrome (NRDS).8
NRDS is a serious respiratory disease in which immature lung development or alveolar dysfunction after birth leads to lack of lung surface active substances on the lung surface and alveolar atrophy in newborns.9 NRDS is characterized by progressive dyspnea and respiratory failure shortly after birth.10,11 Premature infants with NRDS are prone to pulmonary infection, pulmonary hypertension, pulmonary hemorrhage and other complications, which can lead to respiratory failure.12–14 The incidence of NRDS has an increasing trend.15,16 NRDS has a high social burden globally, especially in low-income countries.17,18
The lower the gestational age, the higher the incidence of NRDS, the incidence of ≤25 weeks of gestational age is approximately 91%, the incidence of 26–28 weeks of gestational age is approximately 58%, the incidence of 29–31 weeks of gestational age is about 52%.19 However, in recent years, the incidence of late preterm infants and full-term infants with gestational age >34 weeks has also increased significantly.20 The physiological characteristics of newborns of different gestational ages are different, and the clinical characteristics of NRDS may also different among children of different gestational ages.21 It is of great significance to explore the relationship between the occurrence of NRDS in newborns with different gestational ages and the situation of newborn and pregnant women.
The prognostic nutritional index (PNI) was initially used to evaluate the overall status of the patients undergoing surgery and the risk of postoperative complications.22,23 The PNI mainly reflects the characteristics of serum albumin concentration and total number of lymphocytes in peripheral blood, and is a comprehensive index of body nutrition and immune level.24 Previous studies have shown that PNI is associated with malignant tumors,25,26 heart failure,27 stroke,28 and respiratory diseases.29,30 But the relationship between PNI and the risk of NRDS in newborns of different gestational ages remains unclear. This study mainly analyzed the relationship of PNI and the risk of NRDS in preterm infants of different gestational ages, and provided reference data for the prevention of NRDS in newborns of different gestational ages.
Materials and Methods
Subjects
Data of 2722 preterm infants who were hospitalized at Meizhou People’s Hospital from October 2018 to March 2024 were collected in this retrospective observational study. In this study, premature birth is defined as delivery ≤37 weeks according to gestational weeks at birth. The inclusion criteria for NRDS patients were as follows: (1) newborns who met the diagnostic criteria of the Montreux Criteria for NRDS;14,31 (2) preterm infants with gestational age ≤37 weeks; and (3) complete clinical data. Preterm infants without NRDS who were born at our hospital during the same period were selected as non-NRDS group. The inclusion criteria for non-NRDS were as follows: (1) preterm infants with a gestational age of ≤37 weeks; (2) newborns without NRDS; and (3) clinical data were complete. Exclusion criteria of NRDS patients: (1) newborns with other respiratory diseases causing respiratory distress; (2) newborns with autoimmune diseases or serious infectious diseases; and (3) newborns with congenital diseases. This study was supported by the Ethics Committee of the Meizhou People’s Hospital.
Clinical Data Collected
Clinical data of the neonates and their mothers were collected from the medical records system of our hospital, including: (1) data of neonates’ mothers: adverse pregnancy and birth history, scarred uterus, pregnancy conditions (amniotic fluid contamination, nuchal cord, placental abnormality, and mode of delivery); (2) data of neonates: gender, birth weight, 1-minute Apgar score, 5-minute Apgar score, respiratory distress, serum albumin level, and total lymphocyte count. The PNI was calculated as follows: albumin (g/L) + (5×total lymphocyte count (109/L). According to the gestational age at the time of delivery, the newborns in this study were divided into infants with 34–37 weeks gestational age, infants with 28+1-33+6 weeks gestational age, and infants with ≤28 weeks gestational age. The birth weight of newborns in each gestational age group was referred to the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) standard.32 The diagnostic criteria for infants with large for gestational age (LGA) is that their birth weight is above the 90th percentile of average weight for the same gestational age.33 Small for gestational age (SGA) is diagnosed as having a birth weight below the 10th percentile of the average weight for the same gestational age.34
Statistical Analysis
The data analysis was performed using SPSS 26.0 (IBM Inc., USA). The measurement data are expressed as mean±standard deviation (SD), and the distributions of continuous variables were evaluated using Student’s t-test or the Mann–Whitney U-test. Categorical variables were compared using χ2 test and Fisher’s exact test. When NRDS was regarded as the end point, receiver operating characteristic (ROC) curve analysis was used to determine the optimal cut-off value of the PNI. Adverse pregnancy and birth history of pregnant women, amniotic fluid contamination, nuchal cord, placental abnormality, mode of delivery, gender and birth weight of neonates, 1-minute and 5-minute Apgar scores were selected as covariates in the multivariate logistic regression analysis for the association between the related factors and NRDS, based on estimating the odds ratios (OR) and their 95% confidence intervals (CIs) in preterm infants with different gestational ages. p<0.05 was considered statistically significant.
Result
The Clinical Features of the Preterm Neonates and Comparison of Clinical Features Among NRDS Patients and Controls
There were 1567 (57.6%) male preterm infants and 1155 (42.4%) female preterm infants. There were 1038 (38.1%) newborns born to women with a history of adverse pregnancy, and 109 (4.0%) preterm infants born to mothers with a scarred uterus. During the perinatal period, 63 (2.3%), 6 (0.2%), and 264 (9.7%) neonates showed amniotic fluid contamination, nuchal cord, and placental abnormality, respectively. There were 1163 (42.7%) and 1559 (57.3%) newborns who delivered via spontaneous and caesarean section, respectively. There were 667 (24.5%), 1969 (72.3%), and 86 (3.2%) preterm infants with SGA, normal, and LGA, respectively (Table 1).
|
Table 1 The Clinical Features of the Preterm Neonates and Comparison of Clinical Features Among NRDS Patients and Non-NRDS Neonates |
This study included 1226 NRDS patients and 1496 neonates without RDS. The proportions of mothers with scarred uterus (2.9% vs 4.9%, p=0.011) and amniotic fluid contamination in the perinatal period (1.5% vs 2.9%, p=0.020) in NRDS group were significantly lower than those in non-NRDS group. The proportions of SGA (35.2% vs 15.8%), 1-minute Apgar score <7 (9.2% vs 3.9%), and 5-minute Apgar score <7 (2.5% vs 1.2%) in the NRDS group was higher than those in non-NRDS infants (all p<0.05). The level of PNI (48.42±9.86 vs 51.62±8.90, p<0.001) in NRDS patients was significantly higher than that in non-NRDS infants. The differences of gender of neonates, adverse pregnancy and birth history of pregnant women, nuchal cord, placenta abnormality, and mode of delivery between the two groups were not statistically significant (Table 1).
Comparison of Clinical Features Among Preterm Neonates with Different PNI Levels
Receiver operating characteristic (ROC) curve analysis was used to determine the optimal cutoff value of the PNI to distinguish NRDS from non-NRDS. The critical value of PNI was 46.875 (sensitivity 48.4%, specificity 69.5%, area under the ROC curve (AUC)=0.613) (Figure 1). There were 1050 preterm neonates with PNI<46.875 and 1672 with PNI≥46.875. The proportion of male (62.1% vs 54.7%, p<0.001), and SGA (36.0% vs 17.3%, p<0.001) in preterm neonates with PNI<46.875 were significantly higher than those in preterm neonates with PNI≥46.875. And the proportion of adverse pregnancy and birth history of pregnant women (35.3% vs 39.9%, p=0.019), mothers with scarred uterus (8.4% vs 12.9%, p<0.001), and placenta abnormality (6.9% vs 11.5%, p<0.001) in preterm neonates with PNI<46.875 were significantly lower than those in preterm neonates with PNI≥46.875. The differences of amniotic fluid contamination, nuchal cord, and 5-minute Apgar score between the two groups were not statistically significant (Table 2).
|
Table 2 Comparison of Clinical Features Among Preterm Neonates with Different PNI Levels |
|
Figure 1 ROC curves of PNI for NRDS. Abbreviation: ROC, receiver operating characteristic; PNI, prognostic nutritional index; NRDS, neonatal respiratory distress syndrome. |
Comparison of Clinical Features of NRDS Patients with Different Gestational Weeks at Birth
The difference in the proportion of placental abnormality among infants with 34–37 weeks gestational age, 28+1-33+6 weeks, and infants with ≤28 weeks gestational age was statistically significant (p=0.016). With an increase in gestational age at birth, the proportion of caesarean sections showed an increasing trend (p<0.001). With the decrease of gestational age at birth, the proportion of SGA, and low 1-minute Apgar score showed an increasing trend (all p<0.001). The differences of gender of neonates, adverse pregnancy and birth history of pregnant women, scarred uterus, amniotic fluid contamination, nuchal cord, mode of delivery, and 5-minute Apgar score between the three groups were not statistically significant. With the increase of the gestational age at birth, the PNI level showed an increasing trend (Table 3).
|
Table 3 Comparison of Clinical Features of NRDS Patients with Different Gestational Weeks at Birth |
Logistic Regression Analysis of Predictor Factors of NRDS in Different Gestational Ages at Birth
The results of univariate analysis showed that cesarean section (cesarean section vs spontaneous, odds ratio (OR): 1.503, 95% confidence interval (CI): 1.179–1.918, p=0.001), and low PNI level (<46.875 vs ≥46.875, OR: 1.420, 95% CI: 1.121–1.799, p=0.004) were significantly associated with NRDS in infants with 34–37 weeks gestational age. Adverse pregnancy and birth history of pregnant women (yes vs no, OR: 1.459, 95% CI: 1.102–1.932, p=0.008), SGA (SGA vs normal, OR: 2.145, 95% CI: 1.576–2.919, p<0.001), and low PNI level (<46.875 vs ≥46.875, OR: 1.750, 95% CI: 1.335–2.292, p<0.001) were significantly associated with NRDS in infants with 28+1-33+6 weeks of gestational age. A low PNI level (<46.875 vs ≥46.875, OR: 5.571, 95% CI: 1.782–17.418, p=0.003) was significantly associated with NRDS in infants with gestational age ≤28 weeks (Table 4).
|
Table 4 Associated Factors of NRDS in Different Gestational Ages at Birth by Univariate Logistic Regression Analysis |
Multivariate logistic regression analysis showed that cesarean section (cesarean section vs spontaneous, OR: 1.550, 95% CI: 1.197–2.007, p=0.001), and low PNI level (<46.875 vs ≥46.875, OR: 1.417, 95% CI: 1.110–1.808, p=0.005) were significantly associated with NRDS in infants with 34–37 weeks gestational age. Adverse pregnancy and birth history of pregnant women (yes vs no, OR: 1.507, 95% CI: 1.124–2.019, p=0.006), SGA (SGA vs normal, OR: 1.994, 95% CI: 1.455–2.733, p<0.001), and low PNI level (<46.875 vs ≥46.875, OR: 1.626, 95% CI: 1.230–2.149, p=0.001) were significantly associated with NRDS in infants with 28+1-33+6 weeks gestational age. And low PNI level (<46.875 vs ≥46.875, OR: 5.512, 95% CI: 1.555–19.536, p=0.008) was significantly associated with NRDS in infants with gestational age ≤28 weeks. In other words, newborns with low PNI level were more than 1.4, 1.6, and 5.5 times more likely to develop NRDS than those with high PNI among preterm infants with 34–37 weeks, 28+1-33+6 weeks, and ≤28 weeks gestational age, respectively (Table 5).
|
Table 5 Associated Factors of NRDS in Different Gestational Ages at Birth by Multivariate Logistic Regression Analysis |
Discussion
NRDS has long been one of the most common respiratory diseases in newborns, especially in preterm infants.7,35 The lower the gestational age at birth, the higher the incidence of NRDS.36,37 Studies have found that the incidence of NRDS in preterm infants increases with the decrease of gestational age.19 There may be differences in the risk factors for NRDS among preterm infants with different gestational ages. It is of great significance to explore the relationship between the occurrence of NRDS in preterm infants of different gestational ages and the situation of newborns and pregnant women, and to analyze its clinical characteristics and related risk factors.
Lymphocytes are an important components of the immune system and play a key role in some lung diseases.38,39 Several studies have shown that lymphocyte count is associated with the development and prognosis of respiratory distress.40–42 Albumin is a multifunctional plasma protein, that has important physiological functions in material transport and transportation, maintenance of colloid osmotic pressure, elimination of free radicals, anticoagulation and antithrombosis, and participation in capillary permeability.43–46 The level of albumin level can also reflect the inflammation and nutrient levels of patients, hypoalbuminemia is associated with neonatal infection and poor prognosis.47,48 Several studies have found that albumin level is associated with the onset and outcome of acute respiratory distress.49–51 However, PNI, as a comprehensive index of albumin and lymphocyte levels, has not been reported in relation to respiratory distress. In this study, low PNI level (<46.875) was significantly associated with NRDS in preterm infants of different gestational ages.
There have been some reports on the relationship between PNI and respiratory diseases. Some studies have shown that patients with low PNI levels of non-small cell lung cancer (NSCLC),24,52,53 and small-cell lung cancer (SCLC)54,55 have a worse prognosis than those with high PNI. PNI also can serve as a prognostic biomarker for chronic obstructive pulmonary disease (COPD).56–58 In addition, some studies suggest that PNI can be used as a prognostic indicator for COVID-19 patients.59–61 Moreover, PNI was a prognostic biomarker for community acquired bacterial pneumonia,62 and pulmonary embolism.63
In this study, cesarean section was significantly associated with NRDS in infants at 34–37 weeks gestational age, but not in infants with 28+1-33+6 weeks, and ≤28 weeks gestational age. Some studies have found that cesarean section is an important reasons for NRDS.64 Normal uterine contractions can increase the secretion of adrenaline and promote the secretion of pulmonary surfactant secretion. Compared to newborns born naturally, the role of corticosteroids related to delivery in promoting lung maturation is reduced in newborns born by cesarean section.65 At the same time, newborns born via cesarean section do not undergo birth canal compression during delivery, resulting in delayed removal of lung fluid.66 Therefore, in clinical practice, the relevant indications of cesarean section should be expanded to ensure the safety of children and the impact of cesarean section on children should be reduced.
Low weight infants are mainly seen as premature infants, and some full-term infants can also appear to have low weight for various reasons. Low birth weight may be related to a variety of factors, such as an abnormal umbilical cord, placenta, insufficient nutrition of the mother, backward respiratory system development, and the possibility of NRDS is high. This study also found that SGA was significantly associated with NRDS in infants with 28+1-33+6 weeks gestational age. Some studies have suggested that low birth weight is the main risk factor for NRDS.21,67 However, other studies have suggested that the risk of NRDS is not related to birth weight of preterm infants.68 It may be related to the difference in the number of cases included in different studies.
Summary, cesarean section, and low PNI level (<46.875) were significantly associated with NRDS in infants with 34–37 weeks gestational age; adverse pregnancy and birth history of pregnant women, SGA, and low PNI level (<46.875) were significantly associated with NRDS in infants with 28+1-33+6 weeks gestational age; low PNI level (<46.875) was significantly associated with NRDS in infants with ≤28 weeks gestational age. This study has some limitations that are worth noting. First, because this was a retrospective study, other possible factors influencing NRDS were not included in the analysis. Second, there were fewer patients with amniotic fluid contamination and nuchal cord, and the assessment results for these factors and NRDS may have been biased. Third, this single-center study lacked external data for verification. Further expansion of clinical sample sizes and multi-center prospective studies are needed to confirm the risk factors for NRDS in preterm infants of different gestational ages.
Conclusions
In conclusion, the risk factors for NRDS in preterm infants of different gestational ages are different. Low PNI level is associated with an increased risk of neonatal respiratory distress syndrome in preterm infants with all different gestational ages. In addition, cesarean section was associated with NRDS in infants born at 34–37 weeks gestational; adverse pregnancy and birth history of pregnant women, and SGA were associated with NRDS in infants with 28+1-33+6 weeks gestational age. The above factors should be considered in clinical studies to achieve early detection and prevention to reduce the incidence of NRDS.
Data Sharing Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Ethics Approval
The study was performed under the guidance of the Declaration of Helsinki and approved by the Ethics Committee of Medicine, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences (Clearance No.: 2024-C-60). The parents or legal guardians of all neonates signed informed consent forms.
Acknowledgments
The author would like to thank other colleagues whom were not listed in the authorship of Department of Pediatrics, and Department of Neonatology, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences for their helpful comments on the manuscript.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This study was supported by the Science and Technology Program of Meizhou (Grant No.: 2019B0202001).
Disclosure
The authors declare that they have no competing interests.
References
1. Di Renzo GC, Cabero Roura L, Facchinetti F. et al. Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine. J Matern Fetal Neonatal Med. 2017;30(17):2011–2030. doi:10.1080/14767058.2017.1323860
2. Seidler AL, Libesman S, Hunter KE, et al. Short, medium, and long deferral of umbilical cord clamping compared with umbilical cord milking and immediate clamping at preterm birth: a systematic review and network meta-analysis with individual participant data. Lancet. 2023;402(10418):2223–2234. doi:10.1016/S0140-6736(23)02469-8
3. Possmayer F, Zuo YY, Veldhuizen RAW, Petersen NO. Pulmonary surfactant: a mighty thin film. Chem Rev. 2023;123(23):13209–13290. doi:10.1021/acs.chemrev.3c00146
4. Garcia MJ, Amarelle L, Malacrida L, Briva A. Novel opportunities from bioimaging to understand the trafficking and maturation of intracellular pulmonary surfactant and its role in lung diseases. Front Immunol. 2023;14:1250350. doi:10.3389/fimmu.2023.1250350
5. Dumpa V, Avulakunta I, Bhandari V. Respiratory management in the premature neonate. Expert Rev Respir Med. 2023;17(2):155–170. doi:10.1080/17476348.2023.2183843
6. Cornette L, Mulder A, Debeer A, et al. Surfactant use in late preterm infants: a survey among Belgian neonatologists. Eur J Pediatr. 2021;180(3):885–892. doi:10.1007/s00431-020-03806-1
7. De Luca D. Respiratory distress syndrome in preterm neonates in the era of precision medicine: a modern critical care-based approach. Pediatr Neonatol. 2021;62(Suppl 1):S3–s9. doi:10.1016/j.pedneo.2020.11.005
8. Reynolds P, Bustani P, Darby C, et al. Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline. Neonatology. 2021;118(5):586–592. doi:10.1159/000518396
9. Anciuc-Crauciuc M, Cucerea MC, Tripon F, Crauciuc G-A, Bănescu CV. Descriptive and functional genomics in neonatal respiratory distress syndrome: from lung development to targeted therapies. Int J Mol Sci. 2024;25(1):649. doi:10.3390/ijms25010649
10. Silveira Neves G, Silveira Nogueira Reis Z, Maia de Castro Romanelli R, Dos Santos Nascimento J, Dias Sanglard A, Batchelor J. The role of chest X-ray in the diagnosis of neonatal respiratory distress syndrome: a systematic review concerning low-resource birth scenarios. Glob Health Action. 2024;17(1):2338633. doi:10.1080/16549716.2024.2338633
11. Lavizzari A, Zannin E, Klotz D, Dassios T, Roehr CC. State of the art on neonatal noninvasive respiratory support: how physiological and technological principles explain the clinical outcomes. Pediatr Pulmonol. 2023;58(9):2442–2455. doi:10.1002/ppul.26561
12. Lee M, Wu K, Yu A, et al. Pulmonary hemorrhage in neonatal respiratory distress syndrome: radiographic evolution, course, complications and long-term clinical outcomes. J Neonatal Perinatal Med. 2019;12(2):161–171. doi:10.3233/NPM-1867
13. Maneenil G, Premprat N, Janjindamai W, Dissaneevate S, Phatigomet M, Thatrimontrichai A. Correlation and prediction of oxygen index from oxygen saturation index in neonates with acute respiratory failure. Am J Perinatol. 2024;41(2):180–186. doi:10.1055/a-1673-5251
14. De Luca D, Tingay DG, van Kaam AH, et al. Epidemiology of neonatal acute respiratory distress syndrome: prospective, multicenter, international cohort study. Pediatr Crit Care Med. 2022;23(7):524–534. doi:10.1097/PCC.0000000000002961
15. Legesse BT, Abera NM, Alemu TG, Atalell KA. Incidence and predictors of mortality among neonates with respiratory distress syndrome admitted at West Oromia Referral Hospitals, Ethiopia, 2022. Multi-centred institution based retrospective follow-up study. PLoS One. 2023;18(8):e0289050. doi:10.1371/journal.pone.0289050
16. Donda K, Vijayakanthi N, Dapaah-Siakwan F, Bhatt P, Rastogi D, Rastogi S. Trends in epidemiology and outcomes of respiratory distress syndrome in the United States. Pediatr Pulmonol. 2019;54(4):405–414. doi:10.1002/ppul.24241
17. Tochie JN, Sibetcheu AT, Arrey-Ebot PE, Choukem SP. Global, regional and national trends in the burden of neonatal respiratory failure and essentials of its diagnosis and management from 1992 to 2022: a scoping review. Eur J Pediatr. 2024;183(1):9–50. doi:10.1007/s00431-023-05238-z
18. Hubbard RM, Choudhury KM, Lim G. Treatment patterns and clinical outcomes in neonates diagnosed with respiratory distress syndrome in a low-income country: a report from Bangladesh. Anesth Analg. 2018;126(5):1684–1686. doi:10.1213/ANE.0000000000002865
19. Waitz M, Mense L, Kirpalani H, Lemyre B. Nasal intermittent positive pressure ventilation for preterm neonates: synchronized or not? Clin Perinatol. 2016;43(4):799–816. doi:10.1016/j.clp.2016.07.013
20. Liu H, Li J, Guo J, Shi Y, Wang L. A prediction nomogram for neonatal acute respiratory distress syndrome in late-preterm infants and full-term infants: a retrospective study. EClinicalMedicine. 2022;50:101523. doi:10.1016/j.eclinm.2022.101523
21. Condò V, Cipriani S, Colnaghi M, et al. Neonatal respiratory distress syndrome: are risk factors the same in preterm and term infants? J Matern Fetal Neonatal Med. 2017;30(11):1267–1272. doi:10.1080/14767058.2016.1210597
22. Sun G, Li Y, Peng Y, et al. Impact of the preoperative prognostic nutritional index on postoperative and survival outcomes in colorectal cancer patients who underwent primary tumor resection: a systematic review and meta-analysis. Int J Colorectal Dis. 2019;34(4):681–689. doi:10.1007/s00384-019-03241-1
23. Yang Y, Gao P, Song Y, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol. 2016;42(8):1176–1182. doi:10.1016/j.ejso.2016.05.029
24. Wang Z, Wang Y, Zhang X, Zhang T. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: review and meta-analysis. Clin Chim Acta. 2018;486:303–310. doi:10.1016/j.cca.2018.08.030
25. Ishiguro T, Aoyama T, Ju M, et al. Prognostic nutritional index as a predictor of prognosis in postoperative patients with gastric cancer. vivo. 2023;37(3):1290–1296. doi:10.21873/invivo.13207
26. Shimizu K, Okita R, Saisho S, et al. Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer. Ther Clin Risk Manag. 2015;11:1555–1561. doi:10.2147/TCRM.S92961
27. Zhang X, Su Y. Low prognostic nutritional index predicts adverse outcomes in patients with heart failure: a systematic review and meta-analysis. Angiology. 2024;75(4):305–313. doi:10.1177/00033197231159680
28. Liu M, Sun M, Zhang T, et al. Prognostic Nutritional Index (PNI) as a potential predictor and intervention target for perioperative ischemic stroke: a retrospective cohort study. BMC Anesthesiol. 2023;23(1):268. doi:10.1186/s12871-023-02216-8
29. Wang ZH, Lin YW, Wei XB, et al. Predictive value of prognostic nutritional index on COVID-19 severity. Front Nutr. 2020;7:582736. doi:10.3389/fnut.2020.582736
30. Ekinci I, Uzun H, Utku IK, et al. Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19. Int J Vitam Nutr Res. 2022;92(1):4–12. doi:10.1024/0300-9831/a000730
31. Deliloglu B, Tuzun F, Cengiz MM, Ozkan H, Duman N. Endotracheal surfactant combined with budesonide for neonatal ARDS. Front Pediatr. 2020;8:210. doi:10.3389/fped.2020.00210
32. Villar J, Cheikh Ismail L, Victora CG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st Project. Lancet. 2014;384(9946):857–868. doi:10.1016/S0140-6736(14)60932-6
33. Chandrasekaran N. Induction of labor for a suspected large-for-gestational-age/macrosomic fetus. Best Pract Res Clin Obstet Gynaecol. 2021;77:110–118. doi:10.1016/j.bpobgyn.2021.09.005
34. Damhuis SE, Ganzevoort W, Gordijn SJ. Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology. Obstet Gynecol Clin North Am. 2021;48(2):267–279. doi:10.1016/j.ogc.2021.02.002
35. Ramaswamy VV, Abiramalatha T, Bandyopadhyay T, Boyle E, Roehr CC. Surfactant therapy in late preterm and term neonates with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2022;107(4):393–397. doi:10.1136/archdischild-2021-322890
36. Gould AJ, Ding JJ, Recabo O, et al. Risk factors for respiratory distress syndrome among high-risk early-term and full-term deliveries. J Matern Fetal Neonatal Med. 2022;35(26):10401–10405. doi:10.1080/14767058.2022.2128657
37. Yarci E, Canpolat FE. Evaluation of morbidities and complications of neonatal intensive care unit patients with respiratory disorders at different gestational ages. Am J Perinatol. 2022;29(14):1533–1540. doi:10.1055/s-0041-1722942
38. Ruta VM, Man AM, Alexescu TG. Neutrophil-to-lymphocyte ratio and systemic immune-inflammation index-biomarkers in interstitial lung disease. Medicina (Kaunas). 2020;56(8):381. doi:10.3390/medicina56080381
39. Thomas R, Qiao S, Yang X. Th17/Treg imbalance: implications in lung inflammatory diseases. Int J Mol Sci. 2023;24(5):4865. doi:10.3390/ijms24054865
40. Bano Mehdi K, Jehan S, Akhter M, Angez M, Nasir N. Utility of neutrophil to lymphocyte ratio to predict acute respiratory distress syndrome in COVID-19: short communication. Ann Med Surg Lond. 2023;85(6):3232–3236. doi:10.1097/MS9.0000000000000758
41. Zhang Y, Zhang S. Prognostic value of glucose-to-lymphocyte ratio in critically ill patients with acute respiratory distress syndrome: a retrospective cohort study. J Clin Lab Anal. 2022;36(5):e24397. doi:10.1002/jcla.24397
42. Yang L, Gao C, He Y, et al. The neutrophil-to-lymphocyte ratio is associated with the requirement and the duration of invasive mechanical ventilation in acute respiratory distress syndrome patients: a retrospective study. Can Respir J. 2022;2022:1581038. doi:10.1155/2022/1581038
43. Nishi K, Yamasaki K, Otagiri M. Serum albumin, lipid and drug binding. sub-cellular biochemistry. Subcell Biochem. 2020;94:383–397. doi:10.1007/978-3-030-41769-7_15
44. Rabbani G, Ahn SN. Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: a natural cargo. Int J Biol Macromol. 2019;123:979–990. doi:10.1016/j.ijbiomac.2018.11.053
45. Spinella R, Sawhney R, Jalan R. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatol Int. 2016;10(1):124–132. doi:10.1007/s12072-015-9665-6
46. Wang Y, Wang S, Huang M. Structure and enzymatic activities of human serum albumin. Curr Pharm Des. 2015;21(14):1831–1836. doi:10.2174/1381612821666150302113906
47. Yang C, Liu Z, Tian M, et al. Relationship between serum albumin levels and infections in newborn late preterm infants. Med Sci Monit. 2016;22:92–98. doi:10.12659/msm.895435
48. Wang ZL, An Y, He Y, et al. Risk factors of necrotizing enterocolitis in neonates with sepsis: a retrospective case-control study. Int J Immunopathol Pharmacol. 2020;34:2058738420963818. doi:10.1177/2058738420963818
49. Sipahioglu H, Onuk S. Lactate dehydrogenase/albumin ratio as a prognostic factor in severe acute respiratory distress syndrome cases associated with COVID-19. Medicine. 2022;101(38):e30759. doi:10.1097/MD.0000000000030759
50. Yoo JW, Ju S, Lee SJ, Cho YJ, Lee JD, Kim HC. Red cell distribution width/albumin ratio is associated with 60-day mortality in patients with acute respiratory distress syndrome. Infect Dis. 2020;52(4):266–270. doi:10.1080/23744235.2020.1717599
51. Kumar M, Jain K, Chauhan R, Meena SC. Hypoalbuminemia: incidence and its impact on acute respiratory distress syndrome and 28-day outcome in trauma patients. Eur J Trauma Emerg Surg. 2023;49(5):2305–2314. doi:10.1007/s00068-023-02318-5
52. Nishihara-Kato F, Imai H, Tsuda T, et al. Prognostic potential of the prognostic nutritional index in non-small cell lung cancer patients receiving pembrolizumab combination therapy with carboplatin and paclitaxel/nab-paclitaxel. Oncology. 2024;102(1):30–42. doi:10.1159/000533604
53. Chen T, Liang G, Xiang Z, He J, Xu X, Tang M. Prognostic value of prognostic nutritional index and its variations in advanced non-small-cell lung cancer patients treated with anlotinib monotherapy. J Clin Lab Anal. 2022;36(4):e24300. doi:10.1002/jcla.24300
54. Hong S, Zhou T, Fang W, et al. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumour Biol. 2015;36(5):3389–3397. doi:10.1007/s13277-014-2973-y
55. Bahçeci A, Kötek Sedef A, Işik D. The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer. Anticancer Drugs. 2022;33(1):e534–e540. doi:10.1097/CAD.0000000000001169
56. Peng JC, Nie F, Li YJ, Xu QY, Xing SP, Gao Y. Prognostic nutritional index as a predictor of 30-day mortality among patients admitted to intensive care unit with acute exacerbation of chronic obstructive pulmonary disease: a single-center retrospective Cohort study. Med Sci Monit. 2022;
57. Suzuki E, Kawata N, Shimada A, Sato H. Prognostic Nutritional Index (PNI) as a potential prognostic tool for exacerbation of COPD in elderly patients. Int J Chron Obstruct Pulmon Dis. 2023;18:1077–1090. doi:10.2147/COPD.S385374
58. Yuan FZ, Xing YL, Xie LJ, et al. The relationship between prognostic nutritional indexes and the clinical outcomes of patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2023;18:1155–1167. doi:10.2147/COPD.S402717
59. Demirkol ME, Aktas G, Alisik M, Yis OM, Kaya M, Kocadag D. Is the prognostic nutritional index a predictor of Covid-19 related hospitalizations and mortality? Malawi Med J. 2023;35(1):15–21. doi:10.4314/mmj.v35i1.4
60. Nalbant A, Demirci T, Kaya T, Aydın A, Altındiş M, Güçlü E. Can prognostic nutritional index and systemic immune-inflammatory index predict disease severity in COVID-19? Int J Clin Pract. 2021;75(10):e14544. doi:10.1111/ijcp.14544
61. Wei W, Wu X, Jin C. Predictive Significance of the Prognostic Nutritional Index (PNI) in Patients with Severe COVID-19. J Immunol Res. 2021;2021:9917302. doi:10.1155/2021/9917302
62. De Rose L, Sorge J, Blackwell B, et al. Determining if the prognostic nutritional index can predict outcomes in community acquired bacterial pneumonia. Respir Med. 2024;226:107626. doi:10.1016/j.rmed.2024.107626
63. Hayıroğlu M, Keskin M, Keskin T, et al. A novel independent survival predictor in pulmonary embolism: prognostic nutritional index. Clin Appl Thromb Hemost. 2018;24(4):633–639. doi:10.1177/1076029617703482
64. Li Y, Zhang C, Zhang D. Cesarean section and the risk of neonatal respiratory distress syndrome: a meta-analysis. Arch Gynecol Obstet. 2019;300(3):503–517. doi:10.1007/s00404-019-05208-7
65. Atasay B, Ergun H, Okulu E, Mungan Akın I, Arsan S. The association between cord hormones and transient tachypnea of newborn in late preterm and term neonates who were delivered by cesarean section. J Matern Fetal Neonatal Med. 2013;26(9):877–880. doi:10.3109/14767058.2013.765846
66. Indraccolo U, Pace M, Corona G, Bonito M, Indraccolo SR, Di Iorio R. Cesarean section in the absence of labor and risk of respiratory complications in newborns: a case-control study. J Matern Fetal Neonatal Med. 2019;32(7):1160–1166. doi:10.1080/14767058.2017.1401999
67. Hu Y, Chen X, Wang F, Li C, Yue W, Wei H. Risk factors of neonatal acute respiratory distress syndrome based on the Montreux definition in neonates with sepsis: a retrospective case-control study. Am J Perinatol. 2024;41(8):1019–1026. doi:10.1055/a-1788-5121
68. Chard T, Soe A, Costeloe K. The risk of neonatal death and respiratory distress syndrome in relation to birth weight of preterm infants. Am J Perinatol. 1997;14(9):523–526. doi:10.1055/s-2007-994327
© 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
